Interviewing one of the legendary interviewers in broadcasting history can be a nerve-wracking, intimidating experience. A few minutes into the conversation with Charlie Rose, however, I felt like I was conversing with an old friend.
Guest blog by Brenda Patoine
Underage drinking is a significant public health problem in the United States. While rates of underage drinking have declined steadily in the past decade or so, the most recent National Survey on Drug Use and Health reported that among US youth 12 to 20 years old surveyed about their alcohol use in the past 30 days, 20% reported drinking alcohol and 13% reported binge drinking. Adolescents account for approximately 11 percent of total alcohol consumption in the U.S., according to a CDC fact sheet on underage drinking.
Because the teenage brain is at a highly vulnerable stage of development, early drinking may set the stage for later alcohol abuse. The frontal cortex doesn’t fully develop until around age 25, and emerging data suggest that this executive area of the brain is particularly susceptible to damage from alcohol use during adolescence.
Each year, the Society for Neuroscience recognizes outstanding neuroscientists who have strongly added to public education and awareness about the field. The Dana Foundation sponsors these awards. This year’s award was presented to Paula Croxson, D.Phil., of the Icahn School of Medicine at Mount Sinai, during the society’s annual meeting, in Washington, DC, on Tuesday.
Q: How did you get into doing events like “Pint of Science” gatherings?
Dr. Croxson: I started by taking part in Mount Sinai’s outreach program, MINDS, and through that was introduced to others who were taking part in the Dana Foundation’s Brain Awareness Week efforts in New York (BraiNY). My first event was when I told a story for the science storytelling show The Story Collider. I found myself on stage telling a true, personal story about my grandmother’s Alzheimer’s disease and how my own research into memory disorders helped me understand what she went through. It was incredible. I hadn’t imagined what an impact my story would have on other people, and I hadn’t realized how much more connected it would make me feel to the impact my work could have on the world. It changed my life.
On Saturday, the Society for Neuroscience (SfN) kicked off its annual meeting with 30,000 people registered to attend the five-day program at the Walter E. Washington Convention Center in downtown Washington, DC. The meeting provides one of the world’s largest forums for neuroscientists to debut research and to network with colleagues from around the world.
The Brain Awareness Week (BAW) reception was one of the first events, and it welcomed a diverse group of organizations to showcase their efforts in promoting the annual campaign to the public. President of SfN and member of the Dana Alliance for Brain Initiatives, Eric Nestler welcomed attendees and encouraged them to keep creating compelling content and engaging in BAW with hopes of making it a year-round effort.
The capabilities of neurotechnologies are revolutionizing the path of treatment and prevention for certain illnesses. As they continue to evolve, it’s become necessary for doctors and patients to consider the ethical quandaries that arise with the use of brain-interfacing devices.
“We are at a place where we are unlocking more and more data about peoples’ brains and behaviors, and developing more ways of affecting our brains,” neuroethicist Karola Kreitmair said in an interview with the International Neuroethics Society (INS) back in August. “It’s important that we have an ethical actor at the table to shape that future.”
Kreitmair was this year’s Rising Star Plenary Lecturer at the INS meeting, following a panel presentation on the ethics of neuroscience and neurotechnology. She addressed shared concerns brought up by the three panelists in her lecture, “The Seven Requirements for Ethical Consumer Neurotechnologies.”